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specialized high endothelial venules (HEV) in the course
of their migration from the blood to lymphoid tissues.
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molecular properties. The selectins exhibit rapid bindingCambridge, Massachusetts 02140
kinetics (Alon et al., 1995; Alon et al., 1997), and this
may account for their ability to mediate transient tethers
and to produce a dynamic contact zone that movesSummary
along the vascular endothelium during rolling. Mechani-
cal properties that distinguish this class of adhesionP-, E- and L-selectin constitute a family of cell adhe-
receptors from others that bind with similar kinetics maysion receptors that mediate the initial tethering and
also play a role in function (Alon et al., 1995; Chen et al.,rolling of leukocytes on inflamed endothelium as a
1997; Puri et al., 1998). Structurally similar, the selectinsprelude to their firm attachment and extravasation into
consist of an N-terminal, calcium-dependent lectin do-tissues. The selectins bind weakly to sialyl LewisX
main (Drickamer, 1988), an epidermal growth factor-like(SLeX)-like glycans, but with high-affinity to specific gly-
(EGF) domain, variable numbers of complement regula-coprotein counterreceptors, including PSGL-1. Here, we
tory-like units, a transmembrane domain, and an intra-report crystal structures of human P- and E-selectin
cellular region. The primary basis of adhesion is rela-constructs containing the lectin and EGF (LE) domains
tively weak, calcium-dependent interactions betweenco-complexed with SLeX. We also present the crystal
the lectin domain and glycan ligands on apposing cells.structure of P-selectin LE co-complexed with the N-ter-
Other selectin domains, particularly the EGF domain,minal domain of human PSGL-1 modified by both tyro-
are reported to modulate function, but the nature of theirsine sulfation and SLeX. These structures reveal dif-
contributions is uncertain (Kansas, 1996). Although aferences in how E- and P-selectin bind SLeX and the
number of small and large molecular weight glycansmolecular basis of the high-affinity interaction between
bind to the selectins (Varki, 1994), an epitope displayedP-selectin and PSGL-1.
by the sialyl LewisX (SLeX, NeuNAca2,3Galb1,4[Fuca1,
3]GlcNAc) tetrasaccharide and related structures is aIntroduction
physiologically relevant recognition component common
to all three members of the family (Foxall et al., 1992).The selectins are a family of cell-surface glycoproteins
Structurally diverse glycoprotein counterreceptors,responsible for early adhesion events in the recruitment
including GlyCAM-1, CD34, ESL-1, and PSGL-1 bindof leukocytes into sites of inflammation and their emigra-
the selectins with apparent high-affinity (Kansas, 1996;tion into lymphatic tissues (Kansas, 1996; Vestweber
Vestweber and Blanks, 1999), but their physiologicaland Blanks, 1999). As part of a multistep process
relevancy and the basis of their increased affinity relative(Springer, 1994), selectins promote the initial attachment
to SLeX-type glycans are in most cases uncertain (Varki,(tethering) and subsequent movement (rolling) of leuko-
1994; Varki, 1997). PSGL-1, a mucin-like homodimericcytes over vessel walls where they become activated
glycoprotein expressed by virtually all subsets of leuko-as a consequence of exposure to locally produced che-
cytes and recognized by all three selectins (Sako et al.mokines. Firm adhesion of the leukocytes mediated by
1993; McEver and Cummings, 1997; Yang et al., 1999a)
integrins precedes their extravasation into the underly-
is perhaps the best characterized of these at a structure-
ing tissue. P-selectin (CD62P) and E-selectin (CD62E)
function level. High-affinity P-selectin binding requires
are induced on the surface of vascular endothelium in both a SLeX-containing O-glycan and one or more tyro-
response to inflammatory stimuli but with different ex- sine sulfate residues within the anionic N terminus of
pression kinetics. P-selectin, which is also presented the PSGL-1 polypeptide (Pouyani and Seed, 1995; Sako
by activated platelets, is translocated within minutes et al., 1995; Wilkins et al., 1995). Both tyrosine sulfation
from intracellular stores and promotes the immediate and SLeX modification of this region of PSGL-1 are re-
attachment and rapid rolling of leukocytes over vascular quired for P-selectin function under the influence of
surfaces. In contrast, E-selectin is transcriptionally regu- shear flow (Goetz et al., 1997; Ramachandran et al.,
lated appearing on the activated endothelium within 1999). Furthermore, PSGL-1-deficient mice exhibit se-
hours and produces slower rolling of leukocytes likely vere reductions in P-selectin-mediated cell rolling and
important for their subsequent firm attachment. L-selec- early neutrophil recruitment, demonstrating the impor-
tin (CD62L) is expressed constitutively on leukocytes tance of this counterreceptor for in vivo function (Yang
and may function to amplify inflammatory processes by et al., 1999b). L-selectin also recognizes the N-terminal
promoting leukocyte-leukocyte and leukocyte-endothe- region of PSGL-1 and has similar, if not identical, binding
lium interactions. In addition to its role in inflammation, requirements of P-selectin; the L-selectin/PSGL-1 inter-
L-selectin mediates the attachment of lymphocytes to action may be important for the capture of free-flowing
neutrophils by adherent neutrophils (McEver and Cum-
mings, 1997; Yang et al., 1999a). Although PSGL-1 sup-* To whom correspondence should be addressed (e-mail:
rcamphausen@genetics.com). ports E-selectin binding in a tyrosine sulfate-indepen-
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Figure 1. Comparison of P-LE to the Structure of E-LE (Graves et al., 1994)
(A) Ribbon representation of the optimal superposition of P-LE and the previously described E-LE structure showing overall similarity. P-LE
is in blue and E-LE is in green. The bound calcium ions in the two structures are precisely superimposed and are represented as a single
yellow sphere.
(B) A ball and stick representation of the superposition of P-LE and E-LE residues in the vicinity of the SLeX binding site. The coloring scheme
and superposition of calcium ions is identical to that in Figure 1A. For clarity, only interactions with the bound calcium in E-LE are shown as
dashed lines. The stabilizing hydrogen bond between Arg97 and Asp100 in E-selectin is also shown as a dashed line. For residues that differ
between E- and P-selectin, E-selectin residues are listed first. All structure figures were produced with MOLSCRIPT (Kraulis, 1991) and
RASTER3D (Merrit and Murphy, 1994) except where noted.
dent manner (Pouyani and Seed, 1995; Sako et al., 1995), EGF (E-LE) construct crystallized earlier (Graves et al.,
1994). P-selectin containing only these two domainsthis interaction is not required for cell attachment and
rolling in vivo (Yang et al., 1999b). Additional SLeX-modi- binds to PSGL-1 with high-affinity (Mehta et al., 1997).
P-LE crystals have four copies of P-LE in the asymmetricfied glycoconjugates support binding (Kansas, 1996)
suggesting that E-selectin recognition of PSGL-1 is de- unit. The structure was solved at 2.4 A˚ resolution and
refined to an R-factor of 21.3% and an Rfree of 25.2%pendent upon the presentation of SLeX-type glycans
alone and not on polypeptide-encoded determinants. (Table 1). The P-LE crystal structure adopts an overall
conformation similar to that of the previously describedThe molecular bases of selectin interactions are
poorly characterized. Although the crystal structure of E-LE structure (Graves et al., 1994) consistent with the
z60% sequence identity between the selectins in thesean E-selectin lectin/EGF construct has been solved
(Graves et al., 1994), structures of other selectins and domains (Figure 1A). This results in a r.m.s. difference
of only 0.7 A˚ for their Ca backbones. The lectin and EGFof selectins complexed with SLeX-type glycans and
counterreceptors have not been reported. In an effort domains of P-LE interact via a small interface making
the similarity with the E-LE construct even more strikingto increase our understanding of selectin interactions,
we produced an X-ray crystal structure of the lectin/EGF since this interdomain relationship is also maintained
(Figure 1A). The movement of several loops in the EGF(LE) domains of human P-selectin (P-LE). We introduced
the SLeX tetrasaccharide into these crystals, as well as domain and a small movement of the interdomain angle
within P-LE are responsible for many of the minor differ-into crystals of a human E-selectin construct (E-LE) that
we generated in similar fashion. We also obtained a ences between the two structures. The interdomain
angle also varies slightly between different copies ofcrystal structure of P-LE complexed with the N-terminal
domain of human PSGL-1 that is posttranslationally P-LE in the crystal. This may reflect flexibility in this
region of the molecule or may be an effect of crystalmodified by tyrosine sulfation and SLeX. These struc-
tures reveal the molecular interactions of P- and E-selec- packing forces.
The SLeX binding site is highly conserved betweentin with this common ligand and counterreceptor and
offer insight into the nature of the binding interactions the P-LE and E-LE structures. The common feature of
underlying selectin-mediated leukocyte tethering and this site, and the basis for the metal-dependency of
rolling. selectin function, is the coordination of a calcium ion
by the side chains of Glu80, Asn82, Asn105, and Asp106
Results and Discussion and the backbone carbonyl of Asp106 (Figure 1B). The
binding sites do have differences, however, in one area
defined by the substitution of Arg97-Glu98-Lys99-X-Ray Crystal Structure of the P-Selectin
LE Construct Asp100 in E-selectin with Ser97-Pro98-Ser99-Ala100 in
P-selectin (Figure 1B). In E-LE, Arg97 is stabilized by aWe expressed a human P-selectin construct in CHO
cells that is structurally similar to the E-selectin lectin/ hydrogen bond to Asp100 and stacks on Tyr94, thereby
Structures of Selectin SLeX and PSGL-1 Complexes
469
Table 1. Data Collection, Phasing and Refinement Statistics
Structure P-LE P-LE/SLex E-LE/SLex P-LE/SGP-3 P-LE/SGP-3/Hg
Data Collection
Resolution Range (A˚) 15.0–2.4 (2.49–2.4) 14.0–3.4 (3.46–3.4) 15.0–1.5 (1.55–1.5) 15.0–1.9 (1.97–1.90) 14.0–3.5 (3.62–3.50)
Rsyma (%) 5.2 (22.5) 7.2 (32.2) 4.1 (22.0) 5.8 (27.4) 5.5 (7.5)
% Completeness 95.8 (74.2) 97.8 (100.0) 92.4 (62.0) 98.5 (96.6) 97.0 (94.0)
Total Observations 240,361 44,334 260,283 207,998 33,998
Unique Reflections 32,570 11,667 29,493 44,923 7,240
,I/s(I). 35.7 (6.6) 29.0 (5.4) 47.6 (4.4) 25.5 (3.7) 27.4 (18.2)
Phasingb
Phasing Power
Centrics—Isomorphous 0.94
Acentrics—Isomorphous 1.17
Acentrics—Anomalous 1.47
Isomorphous Difference on I (%) 32.2
Number of Sites 1
FOM (Centric/Acentric) 0.312/0.428
Model Refinement
Resolution (A˚) 14.0–2.4 14.0–3.4 14.0–1.5 14.0–1.9
R-factor (%) 21.3 22.7 19.6 20.4
Rfreec (%) 25.2 32.2 21.7 23.5
,B value. (A˚2) 48.8 54.1 19.9 42.0
RMS deviations from
ideal geometry:
Bonds (A˚) 0.010 0.011 0.009 0.010
Angles (8) 1.46 1.53 1.42 1.54
RMS difference in 3.5 3.5 1.83 3.1
main chain bonded
B values (A˚2)
a Rsym 5 SjIh 2 ,Ih.j/SIh where ,Ih. is the average intensity over symmetry equivalents. Numbers in parenthesis refer to statistics for the final
resolution shell.
b Phasing statistics as reported by SHARP.
c Rfree represents the R-factor for a randomly selected set of reflections representing 5% of the data not used in refinement.
presenting a positively charged surface in this region copies of P-LE within the asymmetric unit contain bound
SLeX; the binding site of the fourth copy is partially oc-(Figure 1B). In contrast, both of these positions are un-
charged, non-interacting residues in P-LE. Lys99 in E-LE cluded by crystal contacts. Our E-LE crystallized under
conditions similar to those employed for the earlier con-points away from the binding site, whereas Ser99 in
P-LE is directed inward (Figure 1B). struct (B. Graves, personal communication) with one
copy in the crystallographic asymmetric unit; it is essen-
tially identical to the earlier structure (Graves et al.,Crystal Structures of P- and E-Selectin
LE Domains Complexed with SLeX 1994). E-LE crystals were soaked with SLeX using condi-
tions that gave diffraction data extending to 1.5 A˚ andP-selectin-mediated, but not E-selectin-mediated, leu-
kocyte rolling and recruitment are dramatically affected clear electron density for the bound ligand (Table 1).
SLeX binds to P- and E-LE, using essentially the samein mice genetically deficient in PSGL-1 (Yang et al.,
1999b). This suggests that, in vivo, E-selectin effectively site and with similar conformation of the tetrasaccharide
(Figure 2A). There are differences that account for theutilizes other SLeX-modified glycoconjugates on leuko-
cytes, whereas P-selectin does not. Although the role altered binding affinity for this ligand, however. The
structures of the SLeX complexes reveal that the interac-of avidity due to differences in selectin expression is
uncertain, differential affinities of E- and P-selectin for tions are almost entirely electrostatic in nature, and the
total buried surface area is small (549 A˚2 in E-LE andleukocyte ligands and counterreceptors are likely impor-
tant factors in this distinction. P-selectin binds SLeX- 501 A˚2 in P-LE) when compared to the size of the free
ligand. In both structures, the selectin-bound calciummodified PSGL-1 with nanomolar binding affinity (Croce
et al., 1998; Mehta et al., 1998). This is significantly higher ion is ligated by the 3- and 4-hydroxyl groups of the Fuc
residue within SLeX (Figure 2B). This arrangement is inin affinity than the E-selectin/PSGL-1 interaction (Moore
et al., 1994). In contrast, P-selectin binds the SLeX ligand sharp contrast to proposed models of selectin/SLeX in-
teractions (Bertozzi, 1995) that predict Fuc ligation towith a KD of 7.8 mM, approximately 10-fold lower affinity
than the E-selectin/SLeX interaction (Poppe et al., 1997). calcium via the 2- and 3-hydroxyl groups based on the
structure of the homologous rat mannose binding pro-To explore the structural basis for the different affinities
for SLeX, we soaked this ligand into preformed crystals tein (MBP) complexed with oligomannose (Weis et al.,
1992). The Fuc hydroxyl groups must provide a largeof P-LE and into crystals of a human E-selectin construct
(E-LE) that was prepared similarly to P-LE. The P-LE/ amount of the SLeX binding energy; they not only coordi-
nate the bound calcium but also form hydrogen bondsSLeX diffraction data extend to 3.4 A˚ (Table 1). Three
Cell
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Figure 2. P-LE/SLeX and E-LE/SLeX Interactions
(A) A ball and stick stereo view of the superposition of SLeX bound to P-LE and E-LE showing the similarity in binding orientation. P-LE
residues are in blue, E-LE residues are in green, and the precisely superimposed calcium ions are shown as a single yellow sphere. SLeX
bound to P-LE is in orange and SLeX bound to E-LE is in purple. Dashed lines represent hydrogen bonds distinguishing NeuNAc binding by
P-LE (Ser99) from E-LE (Arg97). For clarity, residues involved in calcium ligation and hydrogen bond formation to Fuc in SLeX are not labeled.
These are presented in Figure 2B.
(B) Stereo view of SLeX bound to E-LE focusing on the Fuc interaction. E-LE is shown in green, SLeX residues are shown in purple, and the
calcium ion is shown as a yellow sphere. A bound water molecule is shown as a red sphere. Dashed lines represent calcium ligation and
hydrogen bonds. These interactions are identical in P-LE/SLeX except where noted in the text. For clarity, calcium coordination bonds for the
side chain of Glu80 and the backbone carbonyl of Asp106 are not shown (refer to Figure 1B).
(C) Stereo view of SLeX bound to E-LE focusing on the Gal and NeuNAc interactions. Refer to Figure 2B for figure descriptions. P-LE binds
these residues in similar fashion except for differences noted in the text and Figure 2A.
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with selectin residues that are also involved in calcium SGP-1 and SGP-2 (Figure 3A) are forms of SGP-3 con-
taining one and two tyrosine sulfates, respectively. Alsocoordination (Figure 2B). The Fuc 4-hydroxyl group of
resolved by chromatography (Figure 3A) are versions ofSLeX replaces precisely a calcium-ligated water mole-
SGP-3 containing no tyrosine sulfates (glycopeptide-1,cule observed in the unliganded structures and hydro-
GP-1) or containing no carbohydrate (sulfopeptide-1,gen bonds to Asn82 and Glu80 (Figure 2B). The Fuc
SP-1).3-hydroxyl group displaces another calcium-coordi-
We determined the binding affinities of P-LE to thenated water molecule, although its final position is now
individual 19ek peptides by using surface plasmon reso-one A˚ closer to Asn105, to which it hydrogen bonds. In
nance (BIAcore) technology. For comparison, we evalu-the E-LE/SLeX complex, Asn83 rotates its X2 torsion
ated the affinity of P-LE to a soluble, recombinant formangle to 598, so that it now hydrogen bonds a water
of PSGL-1 (sPSGL) (Croce et al., 1998) comprised ofmolecule, that in turn hydrogen bonds to the Fuc 2- and
the entire dimeric, extracellular domain. Consistent with3-hydroxyl groups and Glu107 (Figure 2B). This rotation
earlier studies (Mehta et al., 1998), P-LE binds immobi-also allows the Asn83 side chain to coordinate the cal-
lized sPSGL and 19ek peptides with rapid kinetics (Fig-cium. Asn83 is not seen to move and form these produc-
ure 3B); these interactions are specific based upon con-tive interactions in the P-LE/SLeX complex.
trol experiments using EDTA and neutralizing Mabs (notIn both P- and E-LE complexes, the SLeX Gal residue
shown), and SGP-3 as a soluble inhibitor (Figure 3B).hydrogen bonds to Tyr94 and Glu92, and the carboxyl-
The highest affinity interaction observed for the individ-ate group of NeuNAc hydrogen bonds to Tyr48 (Figure
ual 19ek peptides was to SGP-3 with a KD of 778 nM,2C). The NeuNAc residue makes additional contacts,
which is essentially identical to the P-LE/sPSGL interac-however, in a selectin-specific manner, owing to the
tion (Figure 3C). This argues that SGP-3 functionallysequence differences described above. In P-LE, the
mimics the full-length extracellular PSGL-1 construct4-hydroxyl group of NeuNAc hydrogen bonds to Ser99
and that the N-terminal region of PSGL-1 present in(Figure 2A), and the C-4 of the NeuNAc ring packs
the shorter, monomeric construct constitutes the entireagainst Pro98. A more extensive set of interactions is
recognition region for P-LE. P-LE binds with slightlyobserved within the E-LE complex facilitated by a
lower affinity to the mono (SGP-1) and disulfated (SGP-2)change in conformation of this sugar residue. The posi-
forms of SGP-3 (Figure 3C), but these differences maytioning of NeuNAc within the P-LE/SLeX complex would
be an artifact of the heterogeneity of these species.make unfavorable contacts with Arg99 in E-LE, and so
SGP-1 and SGP-2 are pools comprised of different per-moves further back to allow for better interactions (Fig-
mutations of sulfated Tyr5 (Tys5), Tys7 and/or Tys10 inures 2A). In this arrangement, Arg97 hydrogen bonds
unknown relative quantity (data not shown). SGP-2, forto the glycosidic oxygen and the carboxylate group of
example, likely consists of three isoforms: Tys5/Tys7,NeuNAc (Figure 2C). These differences, combined with
Tys5/Tys10, and Tys7/Tys10. Therefore, the small differ-differences in Fuc binding, appear to be the structural
ences in P-LE binding affinity may reflect preferentialbasis for the higher affinity E-selectin/SLeX interaction.
recognition of an isoform that contains sulfate at a spe-
cific Tyr position(s), but this is masked by slightly lower
Generation of a Functional PSGL-1 N Terminus
affinity interactions with other isoforms. The P-LE bind-
for X-Ray Crystallography
ing affinities to versions of SGP-3 containing only the
We next sought a crystal structure of P-LE complexed SLeX glycan (GP-1) or three sulfotyrosines (SP-1) are
with PSGL-1 to elucidate the structural basis of the high- lower relative to species containing both types of modifi-
affinity interaction, but anticipated that the membrane- cations (Figure 3C), but are considerably greater than
bound form, or large, extracellular constructs of PSGL-1, to a synthetic, unmodified 19ek peptide (not shown).
would prove too heterogeneous for co-crystallization. The affinity of the P-LE/GP-1 interaction, however, is
Therefore, we utilized a highly-truncated Fc construct significantly greater than the P-selectin/SLeX interaction
of human PSGL-1 (19.Fc) that supports high-affinity (Poppe et al., 1997), suggesting that the PSGL-1 poly-
binding to P-selectin (Sako et al., 1995). This construct peptide contributes to binding in the absence of the
encodes the 19 N-terminal amino acids of mature sulfotyrosine modification.
PSGL-1, including three potential Tyr sulfate residues
and a SLeX-modified glycan localized to Thr16. With the X-Ray Crystal Structure of P-LE Bound
specific intention of producing monomeric versions of to the PSGL-1 N-Terminal Peptide
PSGL-1, 19.Fc was modified to include an enterokinase SGP-3 was selected for co-crystallization with P-LE ow-
(EK) cleavage sequence located between the PSGL-1 ing to its highest binding affinity and structural homoge-
and Fc sequences (termed 19ek.Fc) (Goetz et al., 1997). neity. The P-LE/SGP-3 complex was solved at 1.9 A˚ and
Purified 19ek.Fc was digested with EK and the resultant refined to an R-factor of 20.4% and a Rfree of 23.5%
PSGL-1 N-termini (termed 19ek peptides) were resolved (Table 1). Of the 28 amino acids within SGP-3, Glu6
by anion-exchange HPLC (Figure 3A). The major 19ek through Pro18, including Tys7 and Tys10 are visible (Fig-
peptide is the sulfoglycopeptide (termed SGP-3) shown ure 4). Disordered and absent from the structure are
in Figure 3A, inset. The PSGL-1 portion of SGP-3 is polypeptide residues one through five, including Tys5,
posttranslationally modified by sulfate on all three tyro- and residues 19–28 containing the enterokinase-linker
sine residues and by a SLeX-capped O-glycan also found region. All residues of the SLeX-modified O-glycan at
in PSGL-1 isolated from HL-60 cells (Wilkins et al., 1996). Thr16 are observable, except for the NeuNAc(a2,3)-
SGP-3 is structurally similar to a PSGL-1 glycosulfopep- linked to the Gal(b1,3)GalNAc branch (Figure 3A, inset).
tide produced by in vitro synthesis that binds to This residue does not appear to be required for high-
affinity P-selectin binding (Leppanen et al., 1999).P-selectin with high-affinity (Leppanen et al., 1999).
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Figure 3. Resolution and BIAcore Affinity Analysis of the PSGL-1 19ek Peptides
(A) Profile of the PSGL-1 19ek peptides resolved by anion-exchange chromatography. See text for definition of peak labels. Inset. Structure
of the major PSGL-1 19ek peptide SGP-3. ,Q denotes cyclization of the N-terminal Gln residue to pyroglutamate and SO3 represents sulfation
of Tyr residues. The over line in the numbered peptide sequence indicates residues of non-PSGL-1 origin that includes the EK sequence. The
numbering of PSGL-1 residues here and in the text is based upon assigning the N terminus of mature PSGL-1 as residue one consistent with
our earlier study (Sako et al., 1995).
(B) Representative BIAcore sensorgrams of solution-phase P-LE binding to immobilized PSGL-1 constructs. P-LE (at 800 nM concentration)
was injected over sPSGL (left) and SGP-3 (right). Binding signals of P-LE injected other less modified forms of SGP-3 (not shown) were
essentially identical to these results with regards to binding kinetics. P-LE binding to sPSGL, and SGP-3 was inhibited by co-injection with
Structures of Selectin SLeX and PSGL-1 Complexes
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Figure 4. Electron Density of P-LE Bound
SGP-3 Residues Tys7 to Tys10
The stick model is from the final refined coor-
dinates of the P-LE/SGP-3 complex. The
maximum entropy map was calculated using
BUSTER (Bricogne, 1993) including phases
derived from P-LE only and the mercury
heavy atom derivative. This figure was pro-
duced with QUANTA.
Two different views of the P-LE/SGP-3 complex are different P-selectin molecules, in rapid succession and
in highly localized fashion, thereby increasing the effi-presented in Figures 5 and 6. SGP-3 binds with 1:1
stoichiometry to the P-LE lectin domain, with a large ciency of leukocyte tethering and rolling. Also apparent
from examination of the P-LE/SGP-3 complex is thatepitope that excludes 1641 A˚2 from solvent and includes
the SLeX binding site described for the P-LE/SLeX com- the binding of SGP-3 occurs on a face of P-LE essentially
opposite the lectin-EGF domain interface (Figure 6A).plex (Figure 5). Despite the fact that SGP-3 is unstruc-
tured in solution, as determined by NMR studies (D. This argues that the EGF domain of P-selectin does not
participate in direct binding to PSGL-1, but it does notTsao, unpublished observations), and is likely extended
(Li et al., 1996), the bound conformation exhibits a hair- exclude an indirect role in function (see below).
The interactions between P-LE and the SGP-3 poly-pin-like structure (Figure 5). The most N-terminal residue
of SGP-3 in contact with the protein is Tys7, followed peptide are a combination of electrostatic and hy-
drophobic contacts. Tys7 appears to be an importantby three residues in an extended conformation (Figure
5). Residues Tys10 to Leu13 form a turn that alters the component of the high-affinity interaction of PSGL-1
with P-selectin. All three oxygen atoms of the Tys7 sul-direction of the peptide, and the remaining residues run
to Pro18 in a linear fashion. The anionic, sulfotyrosine- fate group hydrogen bond, either directly or via a water
molecule, to P-LE residues (Figure 6B). Tys7 also makescontaining portion of the SGP-3 polypeptide binds the
P-LE surface in a region of positive electrostatic poten- a backbone-backbone hydrogen bond with the amide
nitrogen of Lys112 (Figure 6B) and, through the aromatictial (Figure 5); this region may also support the binding
of a number of inhibitory anionic glycoconjugates, in- ring, several non-polar interactions with the side chains
of Ser47 and Lys113 (not shown). This extensive networkcluding heparin sulfate, fucoidan, and sulfatides (Varki,
1994). In contrast, the SLeX component of SGP-3 inter- of hydrogen and non-polar bonds is reminiscent of
Tys63 in hirugen complexed with a-thrombin (Skrzyp-acts with P-LE in an area of neutral and negative electro-
static potential (Figure 5). The P-LE/SGP-3 complex sug- czak-Jankun et al., 1991). SGP-3 residues Leu8 and
Leu13 pack against one another and lie against the hy-gests that individual monomers within dimeric PSGL-1
provide a complete set of P-selectin binding determi- drophobic surface of P-LE formed by His108 and
Lys111; these interactions must help stabilize the com-nants, a result consistent with recent experiments dem-
onstrating that dimerization of PSGL-1 is not required pact tertiary structure of the peptide. The aromatic ring
of the Tys10 side chain of SGP-3 packs against thesefor in vitro function (Epperson et al., 2000). PSGL-1 di-
merization may be important in vivo, however; individual two leucine residues and orients the sulfate moiety so
that it hydrogen bonds to Arg85. Pro14 of SGP-3 packsmonomers of the PSGL-1 homodimer may engage two
solution-phase SGP-3 (dotted line) but not by a synthetic peptide containing no tyrosine sulfation or glycosylation (dashed line), both at 20
mM concentration. All curves reflect specific binding produced by subtracting non-specific binding from total binding.
(C) Binding affinity determinations of solution-phase P-LE reacted with immobilized sPSGL and purified 19ek peptides by BIAcore analysis.
First row, left-to-right: sPSGL, SGP-3 and SGP-2. Second row, left-to-right: SGP-1, GP-1 and SP-1. P-LE at the indicated concentrations was
reacted with immobilized ligands (to determine the total binding signal) and with control cells containing no ligand (to determine non-specific
binding). The equilibrium responses (Req) at each concentration of P-LE are shown. At each P-LE concentration tested, specific binding
signals (squares) were determined by subtracting non-specific responses (triangles) from total binding signals (diamonds). KDs and standard
deviations were determined by line-fitting of specific binding curves using BIAevaluation software (BIAcore) and are the products of three to
ten separate experiments. KD determinations using line-fitting agreed well with values determined by linear regression analysis of Scatchard
plots (not shown).
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within P-LE, however; the Tys7/Tys10 isoform of SGP-2
may bind with comparable affinity to SGP-3, but this is
masked by slightly lower affinity interactions with the
Tys5/Tys10 and Tys5/Tys7 isoforms. A possible expla-
nation for these inconsistencies is that numerous con-
formations of the PSGL-1 N terminus bind to P-selectin,
the highest affinity of which is revealed by the P-LE/
SGP-3 complex. As noted above, PSGL-1 is an extended
molecule that, in solution, is likely to be highly flexible.
PSGL-1 may bind initially to P-selectin via single, weak
interactions using SLeX or any one of the three Tys resi-
dues (Tys5, Tys7, or Tys10) docked into either of the
two defined sulfotyrosine binding sites. Flexibility of the
PSGL-1 N terminus could then allow formation of com-
plementary interactions that strengthens overall binding
to P-selectin. A threshold level of affinity required for
effective leukocyte tethering and rolling may be ob-
tained by a variety of single or combinations of two
sulfotyrosine residues docked into the defined binding
sites in tandem with the SLeX interaction.
Compared to both unliganded P-LE and the P-LE/
Figure 5. Electrostatic Potential Surface Representation of P-LE SLeX complex, there are several dramatic changes to
with Bound SGP-3 the conformation of P-LE associated with binding of
The peptide portion of SGP-3 is shown in green (sulfur is shown as SGP-3 (Figures 6A and 6C). The most significant of these
a yellow atom) and the carbohydrate portion in blue. Selected P-LE in terms of promoting direct binding contacts to SGP-3
residues important for the interaction with SGP-3 are labeled in
is the translocation of the Asn83 to Asp89 loop in P-LEwhite. For the purpose of orientation, selected SGP-3 residues are
from the periphery to a position near the SLeX bindinglabeled in green and in blue. The figure was made with GRASP
site. This affords the hydrogen bond interactions medi-(Nicholls et al., 1991) and the surface colored with DELPHI (Honig
and Nicholls, 1995). Regions with electrostatic potential less than ated by Arg85 (see above) and brings Asn83 and Glu88
241 kT are in red and those greater than 155 kT are in blue. to positions where they simultaneously ligate the bound
metal and form hydrogen bonds to Fuc (Figure 6C). The
metal ligation by Glu88 now mimics that of MBP (corre-against His108 and also hydrogen bonds to Arg85. The
sponding residue is Glu193), unbound and complexedinteractions mediated by Arg85 appear to be important
with oligomannose (Weis et al., 1992; Weis et al., 1991),determinants for recognition of the PSGL-1 polypeptide,
a feature previously noted as distinguishing this lectinbased upon these results and those of an earlier study
from the earlier E-LE structure (Graves et al., 1994). A
exploring the role of this specific residue (Bajorath et
loop of residues from Arg54 to Glu74 is displaced rela-
al., 1994). Despite the fact that strontium was employed
tive to the uncomplexed P-LE and P-LE/SLeX structures
for crystallography, interactions between the SLeX com-
and partially occupies the space vacated by the Asn83
ponent of SGP-3 and P-LE largely reproduce those ob- to Asp89 loop (Figure 6A). Differences in P-LE conforma-
served for the P-LE/SLeX complex, consistent with the tion are also readily apparent at the interface of the two
ability of this metal to substitute for calcium (Asa et domains resulting in a 528 change in orientation of the
al., 1992). There do not appear to be direct binding EGF domain relative to the lectin domain (Figure 6A).
contributions by glycan residues other than those asso- In unliganded P-LE and the P-LE/SLeX complex, Thr65
ciated with SLeX. packs against the side chain of Trp1 excluding it from
The binding interactions mediated by Tys7 and Tys10 solvent. The movement of loops observed for the P-LE/
within the P-LE/SGP-3 complex are consistent with mu- SGP-3 complex would be expected to expose Trp1 to
tagenesis studies demonstrating a preferential role for solvent, but this residue rearranges to pack between
these PSGL-1 residues for P-selectin-mediated cell roll- Tyr118 of the lectin domain and Glu135 of the EGF do-
ing under shear flow (Ramachandran et al., 1999). In our main. A molecule of 2-methyl-2,4-pentanediol (MPD)
structure, however, we do not observe electron density used for crystallization fills the void created by the move-
for the third tyrosine sulfate residue in PSGL-1, Tys5, ment of the Trp1 side chain molecule (Figure 6A).
and there are no obvious reasons (e.g., steric exclusion Although possibly an artifact of the crystallization con-
due to crystal contacts) that might account for its ab- ditions, the change in the conformation at the lectin-
sence. This lack of interaction appears to be inconsis- EGF domain interface is interesting in light of reports
tent with the observation that sulfation at Tyr5 alone that the EGF domain may modulate selectin function
may support P-selectin-mediated cell rolling, albeit less (Kansas, 1996). As noted for the earlier E-LE crystal
efficiently than PSGL-1 mutants that are presumably structure (Graves et al., 1994), the lectin domain makes
monosulfated at Tyr10 or Tyr7 (Ramachandran et al., a limited number of contacts with EGF residues 135–139;
1999). In addition, this structure information apparently this is a property shared with all of our structures includ-
conflicts with our KD determinations suggesting that tri- ing the P-LE/SGP-3 complex. The small number of inter-
sulfated SGP-3 interacts to a greater degree with P-LE actions between the lectin and EGF domains argues
as compared to disulfated SGP-2. This latter result does that this interface is inherently flexible. Of the three se-
lectins, P-selectin may be the most flexible in this regionnot necessarily imply that three Tys binding sites exist
Figure 6. Structure of the P-LE/SGP-3 Complex and Binding Interactions Involving Tys Residues
(A) Ribbon/stick representation of the P-LE/SGP-3 structure superimposed on the unliganded structure of P-LE. The unliganded structure of
P-LE is shown in blue, complexed P-LE in purple, and SGP-3 in orange. The bound strontium ion in the P-LE/SGP-3 complex is directly
superimposed over the calcium ion in unliganded P-LE and is shown as a green sphere. The MPD molecule that is found at the lectin-EGF
domain interface in the P-LE/SGP-3 complex is shown in dark blue.
(B) Stereo view of a close-up of P-LE/SGP-3 interactions in the region of Tys7 (in orange) illustrating the hydrogen bonding network with P-LE
(purple). The sulfur atom in Tys7 is shown in yellow.
(C) Stereo view of a close-up of the P-LE/SGP-3 interaction in the region of Tys10 and the Fuc binding site illustrating the change in conformation
and binding contacts for the Asn83 to Asp89 loop within P-LE. Uncomplexed P-LE is shown in blue and P-LE complexed with SGP-3 is shown
in purple. SGP-3 residues are shown in orange (the sulfur atom of Tys10 is in yellow) and the bound strontium ion is shown as a green sphere.
The portion of SGP-3 omitted for clarity is shown as an orange ellipse.
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due to substitution of Gly138 for Asn138. Asn138 is inflammation, as well as with sulfated SLeX-type glycans
important for lymphocyte homing. L-selectin may bindconserved in human E- and L-selectin EGF domains
and, in both E-LE crystal structures, forms stabilizing PSGL-1 in a similar fashion to P-selectin based on the
conservation of residues within the SLeX binding sitehydrogen bonds to the lectin domain via two water mole-
cules. In contrast, Gly138 in P-selectin is unable to form and a basic residue (Lys) at position 85. We have ob-
served that a LE construct of L-selectin binds to SGP-3these hydrogen bonds. Therefore, the P-selectin EGF
domain may place fewer restrictions on the movement with weaker affinity (KD 5 40 mM, data not shown) than
that of P-LE. The P-LE/SGP-3 structure predicts thisof the lectin domain. The freedom of motion of the lectin
domain may be essential for maximizing contacts be- lower affinity interaction, as L-selectin lacks the basic
residue at position 114 needed to interact with the sec-tween P-selectin and PSGL-1 on free-flowing leuko-
cytes. ond tyrosine sulfate within PSGL-1. L-selectin binds
weakly to SLeX but with improved affinity to SLeX modi-Our models suggest that P-selectin exists in two con-
formations: a low-affinity form that supports SLeX bind- fied by sulfate at the 6-hydroxyl positions of Gal and/
or GlcNAc (Bistrup et al., 1999) displayed by one or moreing and a high-affinity form that is capable of making
extended contacts with PSGL-1. It is possible that SLeX glycoprotein counterreceptors in HEV of secondary
lymphoid organs (Kansas, 1996). The shared require-binding alone also induces a conformational change in
P-selectin, but this may be restricted by steric contacts ment of sulfate for recognition of these glycans and
PSGL-1 raises the possibility of a common L-selectinin the preformed P-LE crystals. We see no evidence of
even minor structural rearrangements, however, in any binding motif for this posttranslational modification.
Simple modeling of sulfate groups onto SLeX within ourcopy of SLeX-bound P-LE within the crystal. Moreover,
only minor improvements in SLeX binding appear to be complexes indicates that these do not directly superim-
pose with tyrosine sulfates within the SGP-3 structure.associated with this conformational change. Conversion
of the unliganded or SLeX-bound form of P-selectin to Therefore, the orientation of sulfated SLeX within the
L-selectin binding site or the conformation of the lectinthe high-affinity form may occur by one of two possible
mechanisms. Interactions with PSGL-1 may initiate at domain may differ subtly from the structures presented
here. Elucidation of the binding interactions with sul-the P-selectin binding site shown here; this induces con-
formational changes down one face of the lectin domain fated SLeX as well as those with PSGL-1 awaits the
structure determination of L-selectin complexed withthat are ultimately transmitted to the lectin-EGF domain
interface. Alternatively, mechanical perturbation of the this ligand and counterreceptor.
lectin-EGF domain interface (e.g., by nonspecific con-
tact with circulating cells) may activate P-selectin to the Experimental Procedures
high-affinity form by triggering conformational changes
Generation of Constructs and Protein/Peptide Preparationthat move up the face of the lectin domain toward the
Constructs encoding the lectin-EGF (LE) domains of human P- andPSGL-1 binding site. Additional studies are required to
E-selectin fused to the CH2-CH3 region of human IgG1 via an in-further explore these possibilities. tervening enterokinase (EK) cleavage sequence (Asp-Asp-Asp-Asp-
Lys) were expressed in CHO cells and recovered from conditioned
media by protein A sepharose (Pharmacia) chromatography. Mono-Concluding Remarks
meric selectin LE domains were produced by digestion of the di-
meric Fc constructs with EK (LaVallie et al., 1993). The selectin LEWe find that a common element in E- and P-selectin
domains were deglycosylated at 378 C for 48 hr at a ratio of 25
bound to SLeX and P-selectin complexed with PSGL-1 milliunits N-glycanase/mg protein and purified by anion exchange
is an intricate network of relatively few but optimally and hydrophobic interaction chromatography. P-LE and E-LE were
disposed interactions that are largely electrostatic in determined to be correct by MS, monomeric by gel filtration HPLC,
and functional by surface plasmon resonance (BIAcore) analyses.nature. This is consistent with the rapid binding kinetics
The liberated LE-domains correspond to the N-terminal 157 aminodescribed for this family of adhesion receptors. Our re-
acids of the mature proteins beginning at conserved residue Trp1.sults offer a structural basis for affinity differences be-
Both constructs contain the five residue C-terminal EK sequence.
tween E- and P-selectin for this ligand and counter- The expression in CHO cells of a soluble, enterokinase-sensitive
receptor that likely reflects specialized roles in the Fc construct of human PSGL-1 (19ek.Fc) was described earlier
recruitment of leukocytes to sites of inflammation. In (Goetz et al., 1997). 19ek.Fc was digested with EK and the liberated,
heterogenous 19ek peptides were purified to individual species.particular, the structure of the P-LE/SGP-3 complex re-
Amino acid and carbohydrate composition analyses, NMR spectros-veals molecular contacts that likely distinguish PSGL-1
copy, and MALDI-TOF and ESI MS (in the negative ion modes)interactions with P-selectin from those with E-selectin.
before and after proteolytic and glycosidic digestions were used to
In human P-selectin, amino acid residues Arg85 and determine the 19ek peptide structures (J. Rouse, D. Tsao, and
His114 provide critical contacts to the sulfates on Tyr7 R. T. C., unpublished data).
and Tyr10 of PSGL-1. In contrast, these interactions are
presumably not formed in human E-selectin in which P-LE/19ek Peptide Binding Studies
the corresponding residues are Gln85 and Leu114. It is Surface plasmon resonance was performed on BIAcore 2000 and
3000 instruments at 258 C using streptavidin-coated sensor chipsnoteworthy that between different mammalian species
(BIAcore) and HBS-P buffer (BIAcore; 10 mM HEPES [pH 7.4], 150there is an evolutionary conservation of this feature;
mM NaCl, and 0.005% polysorbate 20 [v/v]) adjusted to 1 mM eachsimilar differences in charge also occur at these posi-
CaCl2 and MgCl2. The 19ek peptides and sPSGL, a construct con-tions in the mouse, rat, rabbit, and cow homologues of
sisting of the entire dimeric, extracellular domain of PSGL-1 (Croce
P-selectin and E-selectin. et al., 1998), were biotinylated at Lys residues with Sulfo-NHS-LC-
Our results also provide insights into the nature of Biotin (Pierce). Following biotinylation, sPSGL was reacted with im-
mobilized P-selectin in order to isolate functional material (Sako etL-selectin interactions with PSGL-1 in the context of
Structures of Selectin SLeX and PSGL-1 Complexes
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al., 1995). A synthetic peptide (AnaSpec, Inc.) corresponding to the one calcium ion, and one copy of SLeX. The model contains E-LE
residues 1–157. Residues associated with the EK sequence werepolypeptide portion of SGP-3 was similarly biotinylated. Biotinylated
PSGL-1 constructs were coated onto sensor chips using HBS-P not observed. Statistics are described in Table 1.
The structure of P-LE was solved with molecular replacementbuffer. Glycosylated P-LE was injected over the 19ek peptide,
sPSGL and control surfaces at 40 mL/min. The specificity of binding using the published model of the E-lec/EGF construct (PDB acces-
sion code 1ESL). The program AMORE (CCP4, 1994) was used towas validated by control experiments performed in the presence
of neutralizing Mab to P-selectin, 10 mM EDTA, and soluble 19ek locate all four copies of P-LE. The model was built and refined using
the methods described above giving the statistics in Table 1. Thepeptides (R. Camphausen, unpublished data). Deglycosylated P-LE
bound comparably to the glycosylated version. final model consists of four copies of P-LE with 81% of the residues
in the most favored regions of the Ramachandran plot, 5418 total
atoms, 134 water molecules, two MPD molecules, and four calciumCrystallization and Data Collection
ions. All four copies contain residues 1–157 of the P-selectin se-All diffraction data were collected in-house on Rigaku RU200 gener-
quence and the first Asp residue of the EK sequence. Additionalators running at 5.0 KW with Yale/Molecular Structure Corp. focus-
residues in the EK sequence (one or two) are modeled as alanine.ing mirrors and on RAXIS II or RAXIS IV image plate area detectors
The crystals of P-LE soaked in SLeX were essentially isomorphousexcept where noted.
with the P-LE structure described above. After rigid body refinementCrystals of P-LE were grown at 188C using vapor diffusion from
in CNS, there was clear density for three bound SLeX molecules.a solution containing 10 mg/ml protein, 100 mM Tris-HCl (pH 8.5),
The fourth binding site was partially occluded by crystal contacts,150 mM NaCl, 12 mM CaCl2 , 10% (v/v) 2-methyl-2,4-pentanediol
thus explaining the loss of resolution upon soaking in SLeX. QUANTA(MPD), and 10% (w/v) PEG 6000. These crystals were transferred
was used to model bound SLeX and refit protein residues beforeinto 100 mM Tris-HCl (pH 8.5), 75 mM NaCl, 10 mM CaCl2 , 10%
limited refinement in CNS. This gave a final model consisting of four(v/v) MPD, and 11% (w/v) PEG 6000, then transferred for two hours
copies of P-LE (residue content is identical to unliganded formsto the same buffer diluted by 5% (v/v) with MPD. After a second
above) with 71% of the residues in the most favored Ramachandran5% dilution with MPD the crystal was soaked for 13 hr prior to flash
regions, 5455 total atoms, three SLeX molecules, four calcium ionscooling in liquid propane held at liquid nitrogen temperature. P-LE
and two MPD molecules. The four copies contain the P-selectincomplexed with SLeX (SLeX-b-O-methyl, Toronto Research Chemi-
sequence and portions of the EK sequence as in the above.cals) was obtained using the same methods but with the addition
All attempts to solve the structure of P-LE complexed with theof 8 mM SLeX to the final soaking solution. The space group of the
PSGL-1 19ek peptide SGP-3 by molecular replacement failed. TheP-LE crystals was P21 with cell parameters a 5 81.0 A˚, b 5 60.8 A˚,
heavy atom site was located with Patterson techniques refined inc 5 91.4 A˚, and b5103.68. Soaking crystals in SLeX reduced the
SHARP (de la Fourtelle and Bricogne, 1997). These phases gavemaximum resolution to 3.4 A˚, increased the mosaicity to 1.58 and
poor maps but of sufficient quality to allow positioning of two lectingave cell parameters a 5 81.1 A˚, b 5 60.5 A˚, c 5 91.4 A˚ and b 5
domains from the P-LE structure and independent positioning of103.38. Diffraction data were processed and scaled with DENZO/
two EGF domains. These maps also indicated the presence of boundSCALEPACK (HRL Research, Inc.) giving the statistics reported in
SLeX molecules in the same position as found in the P-LE/SLeXTable 1.
complex and extra density that could not be interpreted. The heavyCrystals of E-LE were obtained using vapor diffusion at 188C from
atom phases were combined with model phases in BUSTER givinga solution containing 30 mg/ml protein, 100 mM HEPES (pH 7.5),
clear maximum entropy maps that allowed fitting of the SGP-3 poly-10 mM Tris-HCl, 200 mM CaCl2, and 15% (w/v) PEG 4000. For com-
peptide and SLeX moieties in QUANTA. This structure was refinedplexes with SLeX, E-LE crystals were transferred to a solution con-
as described above giving statistics in Table 1 and 84% of residuestaining 100 mM HEPES (pH 7.5), 200 mM CaCl2, 30% (w/v) PEG
in the most favored regions of the Ramachandran plot. The final4000, and 15 mM SLeX for 15 hr at 258C. After this initial incubation,
model consists of two P-LE/SGP-3 complexes, 3263 atoms, twocrystals were transferred into 100 mM Tris-HCl (pH 7.4), 300 mM
strontium ions, 224 water molecules, two sodium ions, and sevenNaCl, 2 mM CaCl2, 30% (w/v) PEG 4000, and 15 mM SLeX for an
bound MPD molecules. One copy of the P-LE/SGP-3 complex con-additional hour prior to flash cooling as described above. The E-LE/
tains P-LE residues 1–157 and one residue of the EK sequenceSLeX crystals belonged to space group P212121 with cell parameters
modeled as alanine; the other contains P-LE residues 1–156 anda 5 34.5 A˚, b 5 72.4 A˚, and c 5 77.6 A˚. Diffraction data were
residue 157 modeled as alanine. Both copies contain SGP-3 resi-processed as above.
dues as described in Results and Discussion.Crystals of the P-LE/PSGL-1 19ek peptide (SGP-3) complex were
obtained from 8 mg/ml P-LE, SGP-3 in a 2-fold molar excess, 100
AcknowledgmentsmM HEPES (pH 7.0), 10 mM Tris-HCl, 150 mM NaCl, 4 mM CaCl2,
50 mM SrCl2, 5% (w/v) PEG 6000, and 33% (v/v) MPD. Crystals were
We thank Monique Davies and Kenneth Comess for the develop-transferred into 100 mM HEPES (pH 7.0), 10% PEG 6000, 30% MPD,
ment of the 19ek.Fc cell line, Richard Zollner and his colleagues for100 mM NaCl, and 50 mM SrCl2 for 15 hr prior to flash cooling. A
the generation of large quantities of conditioned media, Mark Stahlmercury-derivatized crystal was obtained by adding 0.5 mM mercury
and Holly Schmidt for purification assistance, Jason Rouse andacetate to the final soaking buffer. The space group of the complex
Desiree Tsao for assistance with the characterization of the 19ekcrystals was found to be I222 with cell parameters a 5 63.4 A˚,
peptides, Craig Ogata of the NSLS at Brookhaven National Labora-b 5 96.8 A˚, and c 5 187.3 A˚. Native diffraction data were collected
tory for assistance with crystallographic data collection, and Davidat beamline X4A at the National Synchrotron Light Source (NSLS)
Erbe for critical reading of the manuscript. We also wish to acknowl-at Brookhaven National Laboratory using a wavelength of 0.99987 A˚.
edge John Knopf and Jasbir Seehra for their support.The mercury derivative data were collected in-house. All data were
reduced as described above giving statistics in Table 1.
Received May 23, 2000; revised September 7, 2000.
Structure Determination and Refinement
References
Crystals of E-LE complexed with SLeX were found to be essentially
isomorphous with those of the previously described E-LE construct
Alon, R., Chen, S., Puri, K.D., Finger, E.B., and Springer, T.A. (1997).
(Graves et al., 1994) with a single copy of E-LE in the crystallographic
The kinetics of L-selectin tethers and the mechanics of selectin-
asymmetric unit. Rigid body refinement within CNS (Brunger et al.,
mediated rolling. J. Cell Biol. 138, 1169–1180.
1998) was used to obtain initial phases that gave clear electron
Alon, R., Hammer, D.A., and Springer, T.A. (1995). Lifetime of thedensity for the bound SLeX. These maps were further improved with
P-selectin-carbohydrate bond and its response to tensile force inthe use of BUSTER (Bricogne, 1993), allowing a model for bound
hydrodynamic flow. Nature 374, 539–542.SLeX to be fitted using QUANTA (Molecular Simulations, Inc.). All
further refinement was performed in CNS, giving a final model with Asa, D., Gant, T., Oda, Y., and Brandley, B.K. (1992). Evidence for
two classes of carbohydrate binding sites on selectins. Glycobiology86% of residues in the most favored region of the Ramachandran
plot and consisting of a total of 1510 atoms, 186 water molecules, 2, 395–399.
Cell
478
Bajorath, J., Hollenbaugh, D., King, G., Harte, W., Eustice, D.C., ligand-1 as a highly extended molecule and mapping of protein
epitopes for monoclonal antibodies. J. Biol. Chem. 271, 6342–6348.Darveau, R.P., and Aruffo, A. (1994). CD62/P-selectin binding sites
for myeloid cells and sulfatides are overlapping. Biochemistry 33, McEver, R.P., and Cummings, R.D. (1997). Role of PSGL-1 binding
1332–1339. to selectins in leukocyte recruitment. J. Clin. Invest. 100, S97–103.
Bertozzi, C.R. (1995). Cracking the carbohydrate code for selectin Mehta, P., Cummings, R.D., and McEver, R.P. (1998). Affinity and
recognition. Chem. Biol. 2, 703–708. kinetic analysis of P-selectin binding to P-selectin glycoprotein li-
gand-1. J. Biol. Chem. 273, 32506–32513.Bistrup, A., Bhakta, S., Lee, J.K., Belov, Y.Y., Gunn, M.D., Zuo, F.R.,
Huang, C.C., Kannagi, R., Rosen, S.D., and Hemmerich, S. (1999). Mehta, P., Patel, K.D., Laue, T.M., Erickson, H.P., and McEver, R.P.
Sulfotransferases of two specificities function in the reconstitution (1997). Soluble monomeric P-selectin containing only the lectin and
of high endothelial cell ligands for L-selectin. J. Cell Biol. 145, epidermal growth factor domains binds to P-selectin glycoprotein
899–910. ligand-1 on leukocytes. Blood 90, 2381–2389.
Bricogne, G. (1993). Direct phase determination by entropy maximi- Merrit, E.A., and Murphy, M.E.P. (1994). Raster3D version 2.0: a
zation and likelihood ranking; status report and perspectives. Acta program for photorealistic molecular graphics. Acta Crystallogr.
Crystallogr. D49, 37–60. D50, 869–873.
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Moore, K.L., Eaton, S.F., Lyons, D.E., Lichenstein, H.S., Cummings,
Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., R.D., and McEver, R.P. (1994). The P-selectin glycoprotein ligand
Pannu, N.S., et al. (1998). Crystallography and NMR system: a new from human neutrophils displays sialylated, fucosylated, O-linked
software suite for macromolecular structure determination. Acta poly-N-acetyllactosamine. J. Biol. Chem. 269, 23318–23327.
Crystallogr. D54, 905–921. Nicholls, A., Sharp, K., and Honig, B. (1991). Protein folding and
CCP4 (1994). The CCP-4 suite: programs for X-ray crystallography. association: insights from the interfacial and thermodynamic prop-
Acta Crystallogr. D50, 760–763. erties of hydrocarbons. Proteins 11, 281–296.
Chen, S., Alon, R., Fuhlbrigge, R.C., and Springer, T.A. (1997). Rolling Poppe, L., Brown, G.S., Philo, J.S., Nikrad, P.V., and Shah, B.H.
and transient tethering of leukocytes on antibodies reveal special- (1997). Conformation of the sLex tetrasaccharide, free in solution and
izations of selectins. Proc. Natl. Acad. Sci. USA 94, 3172–3177. bound to E-, P-, and L-selectin. J. Am. Chem. Soc. 119, 1727–1736.
Croce, K., Freedman, S.J., Furie, B.C., and Furie, B. (1998). Interac- Pouyani, T., and Seed, B. (1995). PSGL-1 recognition of P-selectin
tion between soluble P-selectin and soluble P-selectin glycoprotein is controlled by a tyrosine sulfation consensus at the PSGL-1 amino
ligand 1: equilibrium binding analysis. Biochemistry 37, 16472– terminus. Cell 83, 333–343.
16480. Puri, K.D., Chen, S., and Springer, T.A. (1998). Modifying the me-
de la Fourtelle, E., and Bricogne, G. (1997). Maximum-likelihood chanical property and shear threshold of L-selectin adhesion inde-
heavy-atom parameter refinement for multiple isomorphous re- pendently of equilibrium properties. Nature 392, 930–933.
placement and multiwavelength anomalous diffraction methods. Ramachandran, V., Nollert, M.U., Qiu, H., Liu, W.J., Cummings, R.D.,
Methods Enzymol. 276, 472–494. Zhu, C., and McEver, R.P. (1999). Tyrosine replacement in P-selectin
Drickamer, K. (1988). Two distinct classes of carbohydrate-recogni- glycoprotein ligand-1 affects distinct kinetic and mechanical proper-
tion domains in animal lectins. J. Biol. Chem. 263, 9557–9560. ties of bonds with P- and L- selectin. Proc. Natl. Acad. Sci. USA 96,
13771–13776.Epperson, T.K., Patel, K.D., McEver, R.P., and Cummings, R.D.
(2000). Noncovalent association of P-selectin glycoprotein ligand-1 Sako, D., Chang, X.-J., Barone, K.M., Vachino, G., White, H.M., Shaw,
G., Veldman, G.M., Bean, K.M., Ahern, T.J., Furie, B., et al. (1993).and minimal determinants for binding to P-selectin. J. Biol. Chem.
275, 7839–7853. Expression cloning of a functional glycoprotein ligand for P-selectin.
Cell 75, 1179–1186.Foxall, C., Watson, S.R., Dowbenko, D., Fennie, C., Lasky, L.A., Kiso,
Sako, D., Comess, K.M., Barone, K.M., Camphausen, R.T., Cum-M., Hasegawa, A., Asa, D., and Brandley, B.K. (1992). The three
ming, D.A., and Shaw, G.D. (1995). A sulfated peptide segment atmembers of the selectin receptor family recognize a common carbo-
the amino terminus of PSGL-1 is critical for P-selectin binding. Cellhydrate epitope, the sialyl Lewis X oligosaccharide. J. Cell Biol. 117,
83, 323–331.895–902.
Skrzypczak-Jankun, E., Carperos, V.E., Ravichandran, K.G., Tulin-Goetz, D.J., Greif, D.M., Ding, H., Camphausen, R.T., Howes, S.,
sky, A., Westbrook, M., and Maraganore, J.M. (1991). Structure ofComess, K.M., Snapp, K.R., Kansas, G.S., and Luscinskas, F.W.
the hirugen and hirulog 1 complexes of alpha-thrombin. J. Mol. Biol.(1997). Isolated P-selectin glycoprotein ligand-1 dynamic adhesion
221, 1379–1393.to P- and E-selectin. J. Cell Biol. 137, 509–519.
Springer, T.A. (1994). Traffic signals for lymphocyte recirculationGraves, B.J., Crowther, R.L., Chandran, C., Rumberger, J.M., Li, S.,
and leukocyte emigration: the multistep paradigm. Cell 76, 301–314.Huang, K.S., Presky, D.H., Familletti, P.C., Wolitzky, B.A., and Burns,
D.K. (1994). Insight into E-selectin/ligand interaction from the crystal Varki, A. (1994). Selectin ligands. Proc. Natl. Acad. Sci. USA 91,
structure and mutagenesis of the lec/EGF domains. Nature 367, 7390–7397.
532–538. Varki, A. (1997). Selectin ligands: will the real ones please stand up?
Honig, B., and Nicholls, A. (1995). Classical electrostatics in biology J. Clin. Invest. 100, S31–35.
and chemistry. Science 268, 1144–1149. Vestweber, D., and Blanks, J.E. (1999). Mechanisms that regulate
Kansas, G.S. (1996). Selectins and their ligands: current concepts the function of the selectins and their ligands. Physiol. Rev. 79,
and controversies. Blood 88, 3259–3287. 181–213.
Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both de- Weis, W.I., Drickamer, K., and Hendrickson, W.A. (1992). Structure
tailed and schematic plots of protein structures. J. Appl. Crystallogr. of a C-type mannose-binding protein complexed with an oligosac-
24, 946–950. charide. Nature 360, 127–134.
LaVallie, E.R., Rehemtulla, A., Racie, L.A., DiBlasio, E.A., Ferenz, C., Weis, W.I., Kahn, R., Fourme, R., Drickamer, K., and Hendrickson,
Grant, K.L., Light, A., and McCoy, J.M. (1993). Cloning and functional W.A. (1991). Structure of the calcium-dependent lectin domain from
expression of a cDNA encoding the catalytic subunit of bovine en- a rat mannose-binding protein determined by MAD phasing. Science
terokinase. J. Biol. Chem. 268, 23311–23317. 254, 1608–1615.
Leppanen, A., Mehta, P., Ouyang, Y.B., Ju, T., Helin, J., Moore, K.L., Wilkins, P.P., McEver, R.P., and Cummings, R.D. (1996). Structures
van Die, I., Canfield, W.M., McEver, R.P., and Cummings, R.D. (1999). of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60
A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte cells. J. Biol. Chem. 271, 18732–18742.
adhesion to P-selectin. J. Biol. Chem. 274, 24838–24848. Wilkins, P.P., Moore, K.L., McEver, R.P., and Cummings, R.D. (1995).
Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required forLi, F., Erickson, H.P., James, J.A., Moore, K.L., Cummings, R.D.,
and McEver, R.P. (1996). Visualization of P-selectin glycoprotein high affinity binding to P-selectin. J. Biol. Chem. 270, 22677–22680.
Structures of Selectin SLeX and PSGL-1 Complexes
479
Yang, J., Furie, B.C., and Furie, B. (1999a). The biology of P-selectin
glycoprotein ligand-1: its role as a selectin counterreceptor in
leukocyte-endothelial and leukocyte-platelet interaction. Thromb.
Haemost. 81, 1–7.
Yang, J., Hirata, T., Croce, K., Merrill-Skoloff, G., Tchernychev, B.,
Williams, E., Flaumenhaft, R., Furie, B.C., and Furie, B. (1999b).
Targeted gene disruption demonstrates that P-selectin glycoprotein
ligand 1 (PSGL-1) is required for P-selectin-mediated but not
E-selectin-mediated neutrophil rolling and migration. J. Exp. Med.
190, 1769–1782.
Protein Data Bank ID Codes
Coordinates have been deposited in the Protein Data Bank under
ID codes 1G1Q for P-LE, 1G1R for P-LE/SLex, 1G1T for E-LE/SLex,
and 1G1S for P-LE/SGP-3.
